Latest News
Recent Study Proves Nova Max Plus Glucose Meter More Accurate at Low Blood Levels of Hematocrit (Anemia).
A recent published study shows the Nova Max Plus glucose meter to be more accurate than other leading brands of glucose meters on blood samples that have low levels of hematocrit1. Blood containing a low level of hematocrit (medical term: anemia) has been shown to be a leading cause of inaccuracy for most glucose meters....Click here for complete story...
Nova Diabetes Care Offers Free Diabetes Education Guide
Nova Diabetes Care, distributor of the Nova Max brand of consumer glucose meters, is pleased to offer a free download of its comprehensive Diabetes Education Guide.Click here for complete story...
New Study Demonstrates Nova Max® Plus Meter (SMBG) Is Most Accurate Glucose Meter
Nova Max Plus proved to be more accurate than other leading brand self-monitoring blood glucose meters (SMBG) in a study presented September 14th, 2011 at the European Association for the Study of Diabetes (EASD).Click here for complete story...
Free Brochure on Important Information about Diabetic Ketoacidosis (DKA)
Large accumulations of ketones in the blood can cause diabetic ketoacidosis (DKA), a dangerous condition that requires immediate medical attention.
Click here to download...Nova Diabetes Care Offers Free Nova Max® Link Meter for Medtronic MiniMed Paradigm Pump Users
On May 9, 2011, LifeScan, Inc., makers of the OneTouch® UltraLink brand of blood glucose monitoring systems, announced the termination of their exclusive agreement with Medtronic MiniMed to supply MiniMed Paradigm pump users in the U.S with LifeScan's OneTouch UltraLink glucose meter...
Nova's Diabetes Care Products Held Not To Infringe Roche's Claims
The Honorable Joseph J. Farnan of the United States District Court for the District of Delaware issued an order granting client Nova Biomedical Corporation’s motion for summary judgment of non-infringement of two patents asserted by Roche Diagnostics Operations Inc. and Corange Int’l Ltd...
Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc.
Nova Biomedical Corporation, a leading developer of whole blood analyzers, today announced that the company's independent, wholly owned subsidiary, Sanvita CBGM, LLC, has completed the acquisition of certain assets of Sanvita, Inc., a subsidiary of CCS Medical, Inc...
Nova Biomedical Corporation Triumphs in High-Stakes Trade Secret Litigation in California
Following a three-week trial, a California federal jury on Sept. 11, 2009 awarded a complete victory to Nova Biomedical Corporation against Medtronic MiniMed, Inc., which had brought claims against Nova for misappropriation of trade secrets, breach of contract, tortuous interference and conversion. Medtronic Minimed, a subsidiary of Minneapolis-based Medtronic, Inc., the world's largest medical technology company, had sought actual damages of over $30 million, a permanent injunction, a finding of willful misappropriation and punitive damages...